Scienture Holdings, Inc. Common Stock

SCNXNASDAQUSD
0.41 USD
0.02 (4.48%)AT CLOSE (11:59 AM EDT)
0.42
0.01 (2.37%)
POST MARKET (AS OF 05:56 PM EDT)
Post Market
AS OF 05:56 PM EDT
0.42
0.01 (2.37%)
🟢Market: OPEN

Scienture Holdings, Inc. Common Stock (SCNX) trades at $0.42 per share. Technical and fundamental signals converge bearishtechnicals rate "Strong Sell" while fundamentals read "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. SCNX is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Aug 25, 2026.

Open?$0.43
High?$0.45
Low?$0.41
Prev. Close?$0.43
Volume?325.5K
Avg. Volume?2.5M
VWAP?$0.42
Rel. Volume?0.13x
Bid / Ask
Bid?$0.36 × 100
Ask?$0.49 × 100
Spread?$0.13
Midpoint?$0.42
Valuation & Ratios
Market Cap?17.7M
Shares Out?41.1M
Float?36.8M
Float %?90.5%
P/E Ratio?N/A
P/B Ratio?0.28
EPS?-$0.24
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.
Employees
9
Market Cap
17.8M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2008-02-22
Address
20 AUSTIN BLVD.
COMMACK, NY 11725
Phone: (800) 261 0281
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-2/3)
Medium-Term (Wave)? Bearish(-2/3)
Short-Term (Ripple)? Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
75
Short Sent.?
51
Piotroski F-Score?0/9Weak
Altman Z-Score?-1.24Distress
Confidence?38%Very Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?4.37%Low
Short Interest?1.6M
Days to Cover?1.0
Free Float36.8M
Avg Daily Volume6.4M
Settlement Date2026-08-14
Financial Health
Current Ratio?3.04Strong
Quick Ratio?2.97Strong
Cash Ratio?2.71Strong
Debt/Equity?0.15Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A
P/B?
Peers
100
S&P
97
0.28CHEAP
P/S?
Peers
100
S&P
3
17.84HIGH
P/FCF?
N/A
EV/EBITDA?
S&P
97
-2.5CHEAP
EV/Sales?
Peers
100
S&P
3
19.23HIGH
Returns & Efficiency
ROE?
S&P
8
-15.3%WEAK
ROA?
S&P
3
-11.2%WEAK
Cash Flow & Enterprise
FCF?$-14440576
Enterprise Value?$19.0M
Fundamentals ratios updated end of day